Skip to main content
. 2015 Aug 31;8(2):1231. doi: 10.4022/jafib.1231

Table 4. Acute and long-term outcomes of PV isolation using RF versus the cryoballoon in non-randomized studies.

*Combination of first- and second-generation cryoballoons, **Second-generation cryoballoon only, †Force sensing RF

Study n Paroxysmal AF Acute PV isolation Ablation Time, min Procedure time, min Fluoroscopy time, min PN palsy Other adverse events Freedom from AF during long-term follow-up
Linhart, et al.[68] RF Cryoballoon 20 20 20 (100%) 20 (100%) 100% 81% N/A N/A 200 ± 67 166 ± 39 55 ± 23 41 ± 13 0% 15% 0% 0% 45% at 6 months 50% at 6 months
Kojodjojo, et al.[69] RF Cryoballoon 53 90 53 (100%) 90 (100%) 99% 83% N/A N/A 208 ± 58 108 ± 28 62 ± 36 27 ± 9 0% 2.2% 3.8% 1.1% 72% at 1 year 77% at 1 year
Tayebjee, et al.[70] RF Cryoballoon 25 25 25 (100%) 25 (100%) 100% 76% N/A N/A 35 45 0% 8% 0% 4% 4% 4% 52% at 1 year 56% at 1 year
Kühne, et al.[71] RF Cryoballoon 25 25 25 (100%) 25 (100%) 00% 100% 47 45 197 ± 52 166 ± 32 46 ± 22 61 ± 25 0% 4% 4% 4% 92% at 1 year 88% at 1 year
Sorgente, et al.[72] RF Cryoballoon 29 30 20 (69%) 24 (80%) 100% 100% N/A N/A N/A N/A N/A N/A 0% 10% 13.8% 3.3% 66% at 1 year 66% at 1 year
Herrera Siklódy, et al.[73] RF Cryoballoon 30 30 17 (57%) 21 (70%) 100% 100% 52 ± 21 44 ±6 200 ± 46 177 ± 30 37 ± 16 38 ± 12 0% 6.7% 0% 6.7% 80% at 1 year 63% at 1 year
Schmidt, et al.[74] RF Cryoballoon 2,870 905 2,870 (100%) 905 (100%) 98% 97% 33 45 165 160 24 34 0% 2.1% 4.6% 2.7% N/A N/A
Mugnai, et al.[75] RF Cryoballoon 260 136 260 (100%) 136 (100%) 100% 100% 43 ± 6 45 ± 4 192 ± 49 112 ± 58 36 ± 14 31 ± 17 0% 8.1% 14.2% 11.0% 57% at 23 months 63% at 23 months
Juliá, et al.[76] RF† Cryoballoon* 186 100 186 (100%) 100 (100%) 98% 100% N/A N/A 190 ± 57 117 ± 59 35 ± 19 27 ± 16 N/A N/A N/A N/A 80% at 1 year 81% at 1 year
Aryana, et al.[58] RF Cryoballoon** 422 633 319 (76%) 472 (75%) 99% 98% 66 ± 26 40 ± 14 188 ± 42 145 ± 49 23 ± 14 29 ± 1 0% 7.6% 2.6% 1.6% 60% at 1 year 77% at 1 year
Jourda, et al.[79] RF† Cryoballoon** 75 75 75 (100%) 75 (100%) 100% 100% 2 ± 13 32 ± 3 111 ± 32 134 ± 48 21 ± 8 25 ± 10 0% 17.3% 2.7% 1.3% 88% at 1 year 85% at 1 year